clevidipine has been researched along with Acute Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Binz, S; Joyce, K; Levy, P; McNaughton, C; Miller, J | 1 |
| Calcaterra, D; Cole, JB; Jancik, J; Lam, TS; Reidt, S; Ulici, A | 1 |
| Conklen, K; Deshpande, M; Ferrill, D; Jones, B; Rosenfeldt, Z; Siddiqui, FM | 1 |
| Bergese, S; Graffagnino, C; Hu, MY; LaPointe, M; Lazaridis, C; Lee, K; Love, J; Lynch, G; Schneider, D; Williams, GC | 1 |
| Chandra, A; Char, D; Collins, S; Der Sahakian, G; Ding, L; Dunbar, L; Fermann, G; Fonarow, GC; Garrison, N; Hu, MY; Jourdain, P; Laribi, S; Levy, P; Mebazaa, A; Möckel, M; Mueller, C; Peacock, WF; Ray, P; Singer, A; Ventura, H; Weiss, M | 1 |
| Campagna, JA; Conner, GE; Dahl, GP; Larsson, HP; Qiu, F; Spindler, E; Wang, J | 1 |
| Bergese, SD; Joseph, N; Stoicea, N | 1 |
| Aronson, S; Corwin, HL; Gandhi, SD; Lumb, PD; Newman, MF; Singla, N; Sladen, RN; Warltier, DC | 1 |
| Noviawaty, I; Qureshi, AI; Uzun, G | 1 |
| Aronson, S; Cheung, AT; Dyke, CM; Kereiakes, DJ; Levy, JH; Lumb, PD; Newman, MF; Stierer, KA | 1 |
| Deeks, ED; Keam, SJ; Keating, GM | 1 |
| Aronson, S | 1 |
| Cohen, DL; Townsend, RR | 1 |
| Barrett, TW; Schriger, DL | 1 |
| Bergese, SD; Puente, EG | 1 |
| Ebiasah, R; Erowele, GI; Green, W; Ndefo, UA | 1 |
| Awad, AS; Goldberg, ME | 1 |
4 review(s) available for clevidipine and Acute Disease
| Article | Year |
|---|---|
Hypertension Management in Emergency Departments.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chronic Disease; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Hypertension; Labetalol; Nicardipine; Nitroprusside; Practice Guidelines as Topic; Pyridines; Referral and Consultation; Sodium Chloride Symporter Inhibitors; Undiagnosed Diseases | 2020 |
Clevidipine: a review of its use in the management of acute hypertension.
Topics: Acute Disease; Adult; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Infusions, Intravenous; Pyridines | 2009 |
Clevidipine: a new intravenous option for the management of acute hypertension.
Topics: Acute Disease; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Infusions, Intravenous; Models, Biological; Perioperative Care; Postoperative Complications; Preoperative Care; Pyridines | 2010 |
Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review.
Topics: Acute Disease; Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Critical Care; Humans; Hypertension; Infusions, Intravenous; Perioperative Care; Pyridines | 2010 |
4 trial(s) available for clevidipine and Acute Disease
| Article | Year |
|---|---|
Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial.
Topics: Acute Disease; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cerebral Hemorrhage; Female; Glasgow Coma Scale; Humans; Hypertension; Male; Pyridines; Treatment Outcome | 2013 |
Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO).
Topics: Acute Disease; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyridines; Treatment Outcome | 2014 |
Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adult; Aged; Calcium Channel Blockers; Cardiac Surgical Procedures; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pyridines; Treatment Failure | 2008 |
The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiac Surgical Procedures; Female; Humans; Hypertension; Intraoperative Complications; Male; Nicardipine; Nitroglycerin; Nitroprusside; Perioperative Care; Postoperative Complications; Preoperative Care; Pyridines | 2008 |
10 other study(ies) available for clevidipine and Acute Disease
| Article | Year |
|---|---|
Clevidipine versus sodium nitroprusside in acute aortic dissection: A retrospective chart review.
Topics: Acute Disease; Aged; Aortic Aneurysm, Thoracic; Aortic Dissection; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Nitroprusside; Pyridines; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 2017 |
Comparison of Nicardipine with Clevidipine in the Management of Hypertension in Acute Cerebrovascular Diseases.
Topics: Acute Disease; Aged; Antihypertensive Agents; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Humans; Hypertension; Male; Nicardipine; Pyridines; Retrospective Studies; Time Factors; Treatment Outcome | 2018 |
High affinity complexes of pannexin channels and L-type calcium channel splice-variants in human lung: Possible role in clevidipine-induced dyspnea relief in acute heart failure.
Topics: Acute Disease; Alternative Splicing; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Connexins; Dyspnea; Gene Expression Regulation; Heart Failure; Humans; Lung; Protein Binding; Pyridines | 2016 |
Clevidipine-induced Dyspnea Relief in Acute Heart Failure Patients.
Topics: Acute Disease; Calcium Channel Blockers; Dyspnea; Heart Failure; Humans; Hypertension; Pyridines | 2016 |
Drug evaluation of clevidipine for acute hypertension.
Topics: Acute Disease; Animals; Calcium Channel Blockers; Clinical Trials as Topic; Humans; Hypertension; Pyridines | 2008 |
Novel I.V. drug approved.
Topics: Acute Disease; Calcium Channel Blockers; Drug Approval; Humans; Hypertension; Infusions, Intravenous; Pyridines | 2008 |
Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials.
Topics: Acute Disease; Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Cardiac Surgical Procedures; Female; Humans; Hypertension; Infusions, Intravenous; Intraoperative Complications; Male; Nicardipine; Nitroglycerin; Nitroprusside; Postoperative Complications; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic | 2009 |
A new intravenous calcium channel blocker option to treat acute elevations in blood pressure.
Topics: Acute Disease; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Humans; Hypertension; Infusions, Intravenous; Nicardipine; Pyridines; Treatment Outcome | 2009 |
Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions.
Topics: Acute Disease; Adult; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials, Phase III as Topic; Humans; Hypertension; Infusions, Intravenous; Patient Selection; Pyridines; Research Design; Safety | 2009 |
Clevidipine butyrate: a promising new drug for the management of acute hypertension.
Topics: Acute Disease; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Drug Delivery Systems; Drug Design; Hypertension; Pyridines; Vasodilator Agents | 2010 |